|
Match
|
Document |
Document Title |
|
|
US20120015045 |
FUNCTIONALIZED FULLERENES AS ANTIFUNGAL AGENTS
Functionalized fullerenes are used in a method of combating fungal growth on surfaces and treating fungal diseases of patients. Surfaces that can be treated by the materials comprising an effective...
|
|
|
US20110250240 |
IMMUNE ENHANCING COMPOSITIONS AND METHODS OF USE THEREOF
A method of administering parenterally, particularly intramuscularly, glutamine and cystine and glycine plus selenium; or lactalbumin plus selenium; or lactalbumin and glutamine and cystine and...
|
|
|
US20110318351 |
NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
Improved methods for treatment of cancer which involve the targeting of slow-growing, relatively mutationally-spared cancer stem line are provided. These methods are an improvement over previous...
|
|
|
US20110111054 |
BMP-7 FOR USE IN TREATING VASCULAR SCLEROSIS
The present invention relates to prevention and treatment of vascular sclerosis, vascular calcification (VC) and neointimal hyperplasia using a morphogen.
|
|
|
US20110171062 |
UP-CONVERSION LUMINESCENT COATINGS/MATERIALS FOR ANTIMICROBIAL APPLICATIONS
The present invention provides continuous, non-hazardous sterilization and anti-microorganism protection by the generation of interactive, emission responsive surfaces, coatings, and coating systems.
|
|
|
US20120093931 |
Inhibition of Neovascularization by Cerium Oxide Nanoparticles
The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by...
|
|
|
US20110064712 |
Dietary Supplement Compositions and Methods of Making and Using the Same
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed.
|
|
|
US20110104301 |
METHODS OF REDUCING PAIN AND INFLAMMATION
Provided herein are methods of treating or preventing pain and/or inflammation in a subject comprising administering to the subject a transient receptor potential (TRP) ion channel inhibitor.
|
|
|
US20110280956 |
LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE
The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and...
|
|
|
US20110159056 |
METHODS AND MATERIALS FOR STIMULATING PROLIFERATION OF STEM CELLS
Disclosed herein are methods and materials for influencing proliferation of stem cells. Specifically exemplified herein are compositions comprising cerium oxide nanoparticles which can be used to...
|
|
|
US20100324564 |
PARTICLES, GRAINS OR GRANULES FOR THE TREATMENT OF AN INJURED VERTEBRA
A method is provided for treatment of a condition including at least one weakened vertebra or one compression fracture of a vertebra, wherein in at least one embodiment, the vertebra is injected by...
|
|
|
US20110111007 |
INHIBITION OF RETINAL CELL DEGENERATION OR NEOVASCULARIZATION BY CERIUM OXIDE NANOPARTICLES
The presently claimed and disclosed inventive concept(s) provides methods for reducing, reversing or inhibiting retinal cell degeneration, or neovascularization in tissues of a mammalian subject...
|
|
|
US20110135702 |
SPORICIDAL COMPOSITION FOR CLOSTRIDIUM DIFFICILE SPORES
A cleaning medium or formulation that contains a sporicidal composition is described. The composition includes about 0.1-20% weight/weight of a germinant agent, about 0.01-75% w/w of an...
|
|
|
US20100316718 |
ACTIVATED FOAM
The present invention relates to an activated foam made of a natural or synthetic rubber or a synthetic resin, characterized in that the foam contains a zirconium compound and/or a germanium...
|
|
|
US20110135750 |
ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM
The present invention relates to certain combinations of alkaline earth metal salts and rare earth metal salts which provide an improved denaturing effect on allergens. More particularly, the...
|
|
|
US20100303904 |
TABLET WITH REMEDIAL COMPOSITION AND METHODS FOR TREATING MEDICAL DISORDERS AND AILMENTS
The invention discloses a pharmaceutical composition useful for treatment and prevention of medical disorders and ailments. The aforesaid composition comprises active ingredients comprising;...
|
|
|
US20110270259 |
PASTE-POWDER DUAL POLYMER-BASED BONE CEMENT AND INJECTION APPARATUS FOR SAME
The present invention relates to a paste-powder binary bone cement used in arthroplasty or vertebroplasty, and, more particularly, to a paste-powder binary bone cement which can be directly used at...
|
|
|
US20110171319 |
NUTRITIONAL COMPOSITION MADE USING ISOLATED ORGANIC MATTER
Nutritional compositions, formulations, and intermediates are provided which may be utilized to formulate various sweeteners and other products. The formulations described herein are made from...
|
|
|
US20070184095 |
OSMIUM COMPOUNDS FOR THE TREATMENT OF PSORIASIS
Pharmaceutically acceptable compositions and methods for the treatment of psoriasis are disclosed. The compositions contain osmium compounds. The nominal valence of the osmium in the preferred...
|
|
|
US20110045072 |
PHARMACEUTICAL COMPOSITION, DRESSING AND METHOD FOR TREATING SKIN LESION, INTERMEDIATE COMPOSITION AND PROCESS FOR PREPARING SAID DRESSING, AND USE OF CERIUM SALT ASSOCIATED WITH A COLLAGEN MATRIX
The present invention refers to a pharmaceutical composition for treating skin lesion, comprising a cerium salt on a collagen matrix and a dermatologically acceptable carrier. In addition, the...
|
|
|
US20110129509 |
Titanium Dioxide Dispersion And Cosmetics Containing The Same
The present invention provides a titanium dioxide dispersion having a good dispersibility and also provides a cosmetic containing the same. The titanium dioxide dispersion comprises (a) a...
|
|
|
US20110262486 |
Bone implant and manufacturing method thereof
The invention discloses a bone implant and a manufacturing method thereof. The manufacturing method of the bone implant comprises a step of coating or mixing type II collagen with at least one...
|
|
|
US20050220895 |
Use of gallium to treat inflammatory arthritis
Methods are provided for the use of gallium in the treatment or prevention of inflammatory arthritis conditions such as rheumatoid arthritis.
|
|
|
US20110020456 |
LANTHANUM COMPOSITION
The present invention discloses stable, solid oral pharmaceutical composition comprising Lanthanum carbonate having more than 6 molecules of water per molecule of lanthanum carbonate and...
|
|
|
US20110171320 |
Methods to extend vision to infrared wavelengths
In a method for visualizing an object under conditions of low ambient light, the object to be visualized is exposed to incident electromagnetic radiation having a wavelength greater than what can...
|
|
|
US20100055161 |
HYDROGEL FACE MASK FOR DELIVERING SKIN CARE AGENTS
Skin care can be provided by the skin care devices and compositions described herein. Such a skin care device can be configured to include a biocompatible hydrogel layer including one or more...
|
|
|
US20120070505 |
FUNCTIONAL AMPHIPILIC MOLECULE OR MACROMOLECULE FORMULATIONS WITH MULTIPLE COMPARTMENTS
The invention relates to novel functional amphiphilic molecule or macromolecule formulations with multiple compartments for transporting or targeting at least one therapeutic agent, in particular...
|
|
|
US20100297206 |
Antimicrobial Upconversion System
Antimicrobial articles, systems, and methods may be used for killing, inactivating, and/or inhibiting microorganisms. The antimicrobial articles and systems utilize up-conversion luminescence...
|
|
|
US20110002971 |
CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
The present invention relates to protecting a human from an infection using a disinfecting agent as described herein and a method for use thereof, more particularly to a rare earth-containing...
|
|
|
US20080063728 |
Antimicrobial Glass Surfaces of Glass Powders
The invention relates to a water-insoluble silicate glass powder, wherein the silicate glass powder exhibits glass particles with the following composition in percentage by weight on an oxide...
|
|
|
US20070190173 |
Antioxidant skin compositions and methods of production of the same
Antioxidant dry powder compositions are produced and topically administered externally to skin to enhance the ability of the skin to combat free radicals.
|
|
|
US20050053672 |
Synergistic metal salt-cationic surfactant-organic biocide composition
A biocide composition comprising (a) about 0.05% to about 75% of an acidic metal salt selected from the metal group consisting of aluminum, iron, manganese, and zirconium; (b) about 0.05% to about...
|
|
|
US20120045518 |
ENHANCING COAGULATION OR REDUCING FIBRINOLYSIS
Methods for controlling bleeding (e.g., enhancing coagulation and reducing fibrinolysis) in a subject are disclosed. The methods include selecting a subject in need of enhanced coagulation or...
|
|
|
US20110142894 |
DISPERSION CONTAINING ZINC OXIDE OR TITANIUM DIOXIDE
The present invention has an object to provide a high concentration dispersion of zinc oxide or titanium dioxide which is free of volatile silicones, as well as a cosmetic composition which gives...
|
|
|
US20090297610 |
Composition and system to promote wound healing
An externally applied non-absorbent composition applied to a wound to promote the healing of skin. The composition contains a plurality of granulated minerals to provide a protective cover and to...
|
|
|
US20080063689 |
Dietary supplements containing anthocyanins and methods for using same to enhance creatine absorption and vasodilation
A problem with optimizing the effects of creatine has been the need to utilize large amounts of high glycemic carbohydrates to spike insulin in order to augment the flow of creatine (and other...
|
|
|
US20100316566 |
RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY
The present invention concerns methods and compositions related to a chelator and a HHRT ligand. In specific embodiments of the invention the chelator is conjugated to the HHRT ligand. In another...
|
|
|
US20110318410 |
RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the...
|
|
|
US20110123628 |
RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the...
|
|
|
US20050244492 |
Rapidly disintegrating tablets comprising titanium dioxide
An orally-administered, rapidly disintegrating tablet is provided. The tablet comprises: a titanium dioxide; a super disintegrant; and a sugar alcohol. When immersed in water the tablet has a...
|
|
|
US20110150968 |
DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME
A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or...
|
|
|
US20090214606 |
ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES
The present invention relates to antimicrobial, porous particles, especially porous, non-platelet-like SiO2 particles, comprising an organic, or inorganic antimicrobial compound, or composition,...
|
|
|
US20120020878 |
FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS
The present invention comprises a method for delivering pharmaceutical and/or imaging agents within and/or through the dermal, mucosal and other cellular membranes, and across the blood-brain...
|
|
|
US20080166412 |
METHODS AND MATERIALS FOR STIMULATING PROLIFERATION OF STEM CELL
Disclosed herein are methods and materials for influencing proliferation of stem cells. Specifically exemplified herein are compositions comprising cerium oxide nanoparticles which can be used to...
|
|
|
US20050025805 |
Osmium compounds for reduction of adverse inflammation
Reduction of adverse inflammatory reaction to an implant or a transplant, or following trauma or infection, is achieved through catalysis of dismutation of the superoxide radical anion by an osmium...
|
|
|
US20110027200 |
METHODS TO STABILIZE AND PREVENT BREAKDOWN OF SUNSCREEN AND OTHER TOPICAL AND ORAL PREPARATIONS AND COMPOSITIONS PRODUCED THEREBY
Methods for stabilizing, maintaining the activity of and inhibiting growth of microorganisms in sunscreen preparations, anti-oxidant preparations and topical and oral pills and supplements by...
|
|
|
US20070110823 |
Sintered bioactive ceramic composite implant and preparation thereof
A sintered bioactive ceramic composite for implant having high strength and superior bioactivity and a method of preparing the same are provided. The composite includes a zirconia-alumina...
|
|
|
US20120064172 |
BONE FILLING MATERIAL COMPRISING SINTERED TITANIUM DIOXIDE AND DEXTRIN AND METHOD FOR RECONSTRUCTING BONE DEFECTS USING THE SAME
A bone filling material comprising sintered titanium dioxide and dextrin and a method for reconstructing bone defects which comprises filling the bone defects in an animal with the bone filling...
|
|
|
US20100317519 |
Mixtures and methods for the induction of resistance in plants
Mixtures are described comprising two or more compounds selected from at least two of the following groups: i) salicylic acid and/or its functional analogous products (ESA), ii) promoting compounds...
|
|
|
US20120058200 |
PROCESS FOR THE PREPARATION OF LANTHANUM CARBONATE DIHYDRATE
Present invention relates to a process for the preparation and pharmaceutical usage of dihydrate form of lanthanum carbonate. Present process produces lanthanum carbonate dihydrate (La2(CO3)3.2H2O)...
|